Work

LY-2140023, a prodrug of the group II metabotropic glutamate receptor agonist LY-404039 for the potential treatment of schizophrenia.

Year: 2010

Type: article

Source: PubMed

Authors: Mario Mezler, Hervé Geneste, Laura Gault, Gerard J Marek

Institution: Abbott (United States)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W71748888

FWCI: 4.38

Cites:

Cited by: 47

Related to: 10